Intravenous Antimicrobial Starts among Hemodialysis Patients in the National Healthcare Safety Network Dialysis Component, 2016-2020

NHSN total IV antimicrobial start rates for patients on hemodialysis decreased from 2016 to 2020, but rates unsupported by NHSN surveillance documentation did not. There were 80% of reporting hemodialysis facilities that had ≥1 unsupported IV antimicrobial start, and the fraction of facilities with...

Full description

Saved in:
Bibliographic Details
Published in:Kidney360 2023-07, Vol.4 (7), p.971-975
Main Authors: Wilson, W Wyatt, Gouin, Katryna A, Fike, Lucy, Apata, Ibironke W, Bell, Jeneita M, Edwards, Jonathan R, Novosad, Shannon, Kabbani, Sarah
Format: Article
Language:English
Subjects:
Anti-Infective Agents - adverse effects
Brief Communication
Catheter-Related Infections - epidemiology
Catheter-Related Infections - prevention & control
Dialysis
Health Facilities
Humans
Patients
Renal Dialysis - adverse effects
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:NHSN total IV antimicrobial start rates for patients on hemodialysis decreased from 2016 to 2020, but rates unsupported by NHSN surveillance documentation did not. There were 80% of reporting hemodialysis facilities that had ≥1 unsupported IV antimicrobial start, and the fraction of facilities with unsupported starts increased yearly. Accurate reporting and timely review of antimicrobial data is critical to understanding prescribing trends and practices in hemodialysis facilities.
ISSN:2641-7650
2641-7650
DOI:10.34067/KID.0000000000000167